Unknown

Dataset Information

0

Kidney Transplantation from a Hepatitis C Virus-positive Donor to a Hepatitis C Virus-negative Recipient.


ABSTRACT: Kidney transplantation from a hepatitis C virus (HCV)-positive donor to an HCV-negative recipient till recently has been a contraindication. In view of the excellent sustained virological response (SVR) rates with directly acting antiviral agents, HCV-positive donors are being considered for the HCV-negative recipients in a few centers. We report the successful transplantation of an HCV-negative recipient transplanted with an HCV-positive donor kidney. Donor was treated with sofosbuvir and ribavirin for 12 weeks. At 10th and 16th weeks of starting treatment, her HCV-RNA PCR was negative. Three weeks later, transplantation was performed with basiliximab induction and triple immunosuppression with tacrolimus, mycophenolate, and prednisolone. The recipient was administered sofosbuvir and ribavirin for 12 weeks. He attained good graft function with a stable creatinine. His serial alanine transaminases were normal on 3rd, 6th, and 12th months, respectively. Six months posttransplant his anti-HCV antibody, and HCV-RNA PCR were negative.

SUBMITTER: Kamalkiran M 

PROVIDER: S-EPMC6309394 | biostudies-other | 2018 Nov-Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Kidney Transplantation from a Hepatitis C Virus-positive Donor to a Hepatitis C Virus-negative Recipient.

Kamalkiran M M   Ravikiran V V   Shashidhar C C   Prasad K V R KVR   Yeldandi V V  

Indian journal of nephrology 20181101 6


Kidney transplantation from a hepatitis C virus (HCV)-positive donor to an HCV-negative recipient till recently has been a contraindication. In view of the excellent sustained virological response (SVR) rates with directly acting antiviral agents, HCV-positive donors are being considered for the HCV-negative recipients in a few centers. We report the successful transplantation of an HCV-negative recipient transplanted with an HCV-positive donor kidney. Donor was treated with sofosbuvir and ribav  ...[more]

Similar Datasets

| S-EPMC8640566 | biostudies-literature
| S-EPMC7311252 | biostudies-literature
| S-EPMC7136432 | biostudies-literature
| S-EPMC7594852 | biostudies-literature
| S-EPMC8073960 | biostudies-literature
| S-EPMC5569958 | biostudies-literature
| S-EPMC7608998 | biostudies-literature
| S-EPMC6324912 | biostudies-literature
| S-EPMC8236826 | biostudies-literature